Company profile
Arsanis company profile
Arsanis is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. A deep understanding of the pathogenesis of infection, paired with access to some of the most advanced mAb discovery techniques and platforms available today, has positioned Arsanis to build and advance a pipeline of novel mAbs with multiple mechanisms of action and high potency against their intended targets. The company’s lead clinical program, ASN100, is aimed at serious Staphylococcus aureus infections and is being evaluated in Phase 2 clinical trial for the prevention of S. aureus pneumonia in high-risk, mechanically ventilated patients...... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- http://www.arsanis.com
- Contact email
- [email protected]
- Phone number
- 431-799-0117
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2010-01-01
Headquarters
- Headquarters
- Vienna, Vienna, Austria
- Postal code
- A-1030
- Country code
- AT
- Continent
- Europe